Latest Insider Transactions at Tenax Therapeutics, Inc. (TENX)
This section provides a real-time view of insider transactions for Tenax Therapeutics, Inc. (TENX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of TENAX THERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of TENAX THERAPEUTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 08
2024
|
Michael H. Davidson |
BUY
Open market or private purchase
|
Direct |
2,500
+46.46%
|
-
|
|
Aug 08
2024
|
Gerald T Proehl |
BUY
Open market or private purchase
|
Direct |
1,666
+49.99%
|
-
|
|
Sep 21
2022
|
Stuart Rich Chief Medical Officer |
BUY
Bona fide gift
|
Indirect |
1,909,585
+50.0%
|
-
|
|
Sep 21
2022
|
Stuart Rich Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
1,909,585
-81.82%
|
-
|
|
Aug 11
2022
|
Declan Doogan |
BUY
Bona fide gift
|
Direct |
567,871
+13.5%
|
-
|
|
Aug 11
2022
|
Declan Doogan |
SELL
Bona fide gift
|
Indirect |
567,871
-100.0%
|
-
|
|
Nov 29
2021
|
Stuart Rich Chief Medical Officer |
BUY
Bona fide gift
|
Indirect |
1,909,585
+50.0%
|
-
|
|
Nov 29
2021
|
Stuart Rich Chief Medical Officer |
SELL
Bona fide gift
|
Indirect |
1,909,585
-100.0%
|
-
|
|
Oct 12
2021
|
Stuart Rich Chief Medical Officer |
BUY
Bona fide gift
|
Indirect |
1,909,585
+50.0%
|
-
|
|
Oct 12
2021
|
Stuart Rich Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
1,909,585
-45.0%
|
-
|
|
Jun 30
2021
|
Declan Doogan |
SELL
Bona fide gift
|
Direct |
567,871
-18.5%
|
-
|
|
Jun 11
2021
|
Michael H. Davidson |
BUY
Grant, award, or other acquisition
|
Direct |
512,000
+45.77%
|
-
|
|
Jun 11
2021
|
Stuart Rich Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,581,000
+45.77%
|
-
|
|
Jun 11
2021
|
Declan Doogan |
BUY
Exercise of conversion of derivative security
|
Direct |
3,070,000
+45.77%
|
-
|
|
Jan 15
2021
|
Stuart Rich Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,581
+50.0%
|
-
|
|
Jan 15
2021
|
Stuart Rich Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
662,517
+50.0%
|
-
|
|
Sep 08
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Sep 08
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Direct |
8,543
+0.42%
|
$8,543
$1.46 P/Share
|
|
Sep 04
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Sep 04
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Direct |
23,457
+1.15%
|
$23,457
$1.41 P/Share
|
|
Sep 03
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Sep 03
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Direct |
36,000
+1.78%
|
$36,000
$1.39 P/Share
|
|
Sep 02
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Sep 02
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Direct |
20,000
+1.01%
|
$20,000
$1.47 P/Share
|
|
Sep 01
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Sep 01
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Direct |
30,000
+1.53%
|
$30,000
$1.46 P/Share
|
|
Aug 31
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Aug 31
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Direct |
20,000
+1.04%
|
$20,000
$1.45 P/Share
|
|
Aug 27
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Aug 27
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Direct |
12,000
+0.63%
|
$12,000
$1.5 P/Share
|
|
Aug 26
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Aug 26
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Direct |
12,000
+0.64%
|
$12,000
$1.5 P/Share
|
|
Aug 25
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Aug 25
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Direct |
17,211
+0.92%
|
$17,211
$1.53 P/Share
|
|
Aug 24
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Aug 24
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Direct |
5,692
+0.31%
|
$5,692
$1.47 P/Share
|
|
Aug 21
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Aug 21
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Direct |
116,242
+5.96%
|
$116,242
$1.44 P/Share
|
|
Aug 20
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Aug 20
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Direct |
124,472
+6.75%
|
$124,472
$1.53 P/Share
|
|
Aug 19
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Aug 19
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Direct |
70,767
+4.25%
|
$70,767
$1.45 P/Share
|